Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

December 3, 2009

Symposium to Discuss Key Intellectual Property Issues in India

Leading intellectual property attorney Mark Peroff, Co-Chair of law firm Hiscock & Barclay LLP's Intellectual Property & Technology Practice Area, will be attending the Fédération Internationale des Conseils en Propriété Industrielle's (FICPI) India Symposium in New Delhi, where a number of key intellectual property issues for Indian companies will be discussed. FICPI is world-wide organization of intellectual property attorneys and the symposium will take place from December 9-11.

Recently, Hiscock & Barclay launched trademark services for companies from India, an effort which is being led by Mr. Peroff, who is one of the leading trademark attorneys in the United States, having filed more than 6,700 trademarks over the course of his career.

With its leading pharmaceutical companies and a rapidly growing high-tech sector, India has emerged as an important country in the world of IP. The FICPI India Symposium will address a wide range of topics affecting IP professionals, including a session on "Generic Pharma v. Research Based Pharma" and "Protection of IT and Software."

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Changes to Delaware Corporate Law Aim to Preserve Its Leadership Position

Alerts

Non-Judicial Collateral Remedies, Part 1 – Collection and Enforcement Rights

Alerts

Recent US Supreme Court Decision Will Spur ERISA Litigation

Alerts

Proposed Endangered Species Act Change Seeks to Redefine "Harm"

Alerts

Natural Gas Bans in New York State Take Shape: Exemptions and Lawsuits Under Scrutiny

Alerts

Here We Go Again: Second Circuit Makes Additional Certification Attempt Regarding the New York Foreclosure Abuse Prevention Act

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out